| Psoriasis |
1 |
1 |
| Biologic Therapy |
0 |
1 |
| Biosimilars |
0 |
0.94 |
| Psoriatic Arthritis |
0 |
0.36 |
| Crohn Disease |
0 |
0.25 |
| Ulcerative Colitis |
0 |
0.21 |
| Arthritis |
0 |
0.16 |
| Colitis |
0 |
0.16 |
| Plaque Psoriasis |
0 |
1 |
| Inflammatory Bowel Disease |
0 |
0.14 |
| Child |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.08 |
| Interleukin |
0 |
0.08 |
| Monoclonal Antibody |
0 |
0.08 |
| Pharmacokinetics |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.07 |